Sub-miniature plastic fuse
    141.
    发明授权
    Sub-miniature plastic fuse 失效
    小型塑料保险丝

    公开(公告)号:US5287079A

    公开(公告)日:1994-02-15

    申请号:US973790

    申请日:1992-11-09

    Abstract: There is provided a fast acting subminiature cylindrical fuse having a cylindrical cover substantially locked onto a cylindrical base. The locking mechanism for the cover comprises a plurality of grooves and a plurality of corresponding projections on the internal surface of the cover and the external surface of the fuse base. The lock projections have a relatively straight diverging upper surface and a rounded bottom locking surface. The fuse base has a spacing ridge on the bottom thereof that spaces the fuse bottom surface above a circuit board surface. The fuse also has a plurality of pressure relieving passageways extending from inside the fuse to the outside of the fuse.

    Abstract translation: 提供了一种快速作用的超小型圆柱形保险丝,其具有基本锁定在圆柱形基座上的圆柱形盖。 盖的锁定机构包括多个凹槽和在盖的内表面和熔断器基座的外表面上的多个对应的突起。 锁定突起具有相对直的发散的上表面和圆形的底部锁定表面。 保险丝座在其底部具有间隔脊,其将保险丝底表面置于电路板表面之上。 保险丝还具有从保险丝内部延伸到保险丝外部的多个减压通路。

    MODIFIED ANTI-INFLAMMATORY PROTEINS AND METHOD OF USE

    公开(公告)号:US20240400649A1

    公开(公告)日:2024-12-05

    申请号:US18414112

    申请日:2024-01-16

    Abstract: A modified Ac-TMP-2 protein lacks one or a plurality of acidic C-terminal amino acids normally present in a full-length or wild-type Ac-TMP-2 protein and may also lack one or a plurality of N-terminal amino acids while retaining the amino acid sequence C-S-C at or near the N-terminus. The modified Ac-TMP-2 protein may be useful in method and composition for reducing or alleviating inflammation in a subject. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.

    Modified anti-inflammatory proteins and method of use

    公开(公告)号:US10822395B2

    公开(公告)日:2020-11-03

    申请号:US15023165

    申请日:2014-09-18

    Abstract: A modified Ac-TMP-2 protein lacks one or a plurality of acidic C-terminal amino acids normally present in a full-length or wild-type Ac-TMP-2 protein and may also lack one or a plurality of N-terminal amino acids while retaining the amino acid sequence C—S—C at or near the N-terminus. The modified Ac-TMP-2 protein may be useful in method and composition for reducing or alleviating inflammation in a subject. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.

    Wound Healing Peptide
    148.
    发明申请

    公开(公告)号:US20190194279A1

    公开(公告)日:2019-06-27

    申请号:US16329800

    申请日:2017-09-04

    CPC classification number: C07K14/475 A61K38/00 A61P17/02 A61P43/00

    Abstract: Peptides derived from the N-terminal region of granulin have activity in promoting cell proliferation, migration and/or wound healing. Furthermore, an additional disulphide bond may be engineered into such peptides to improve or otherwise modify the folding of the peptide. The peptides may also be modified such as at proline residues improve the ability of the peptide to promote cell proliferation.

    Method for treating inflammation with an Ac-TMP-2 protein

    公开(公告)号:US09637527B2

    公开(公告)日:2017-05-02

    申请号:US14384681

    申请日:2013-03-13

    CPC classification number: C07K14/4354 A61K38/57 A61K39/0003 A61K45/06

    Abstract: A method for reducing or alleviating inflammation in a subject includes administering to the subject a therapeutically effective amount of: (a) Ac-TMP-1 or a biologically active fragment or variant of Ac-TMP-1; (b) Ac-TMP-2 or a biologically active fragment or variant of Ac-TMP-2; or (c) a combination of (a) and (b), to thereby reduce or alleviate inflammation in the subject. A method for preventing or treating asthma or inflammatory bowel disease in a subject includes administering to the subject a therapeutically effective amount of: (a) Ac-TMP-1 or a biologically active fragment or variant of Ac-TMP-1; (b) Ac-TMP-2 or a biologically active fragment or variant of Ac-TMP-2; or (c) a combination of (a) and (b), to thereby prevent or treat asthma or inflammatory bowel disease in the subject. The subject may be a mammal, inclusive of humans.

Patent Agency Ranking